VIRACTA THERAPEUTICS INC shareholders Q2 2024

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 41 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

VIRACTA THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$374,9950.08%
Aisling Capital Management LP 288,571$156,8960.07%
BVF INC/IL 3,614,662$1,965,2920.06%
Planning Capital Management Corp 7,272$3,9540.00%
Laurion Capital Management LP 407,299$221,4480.00%
WealthTrust Axiom LLC 11,396$6,1960.00%
TRUST CO OF TOLEDO NA /OH/ 12,317$6,6970.00%
HoyleCohen, LLC 14,000$7,6120.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 74,000$40,2340.00%
INSPIRION WEALTH ADVISORS, LLC 15,000$8,1560.00%
XTX Topco Ltd 19,201$10,4400.00%
RP Management, LLC 3,700$1,9980.00%
Virtu Financial LLC 30,789$170.00%
Parallel Advisors, LLC 8$40.00%
WELLS FARGO & COMPANY/MN 171$930.00%
Beacon Pointe Advisors, LLC 15,000$8,1560.00%
BANK OF AMERICA CORP /DE/ 12,496$6,7850.00%
GEODE CAPITAL MANAGEMENT, LLC 270,773$147,2580.00%
ACADIAN ASSET MANAGEMENT LLC 10,908$50.00%
IAG Wealth Partners, LLC 3,000$1,6310.00%
External links

This page lists VIRACTA THERAPEUTICS INC's shareholders in Q2 2024. To view VIRACTA THERAPEUTICS INC's shareholder history, click here.